Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6501.5000
-36.50
(
-0.56
%)
NSE
May 23, 2025
10:47 AM
New 52W High in past week
Volume:
67,270
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
08 Nov 2022
6501.50
-0.56%
DIVI'S LABORATORIES
Hold:
Divi's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 3300
Target
Prabhudas Lilladhar
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Market trades higher, Gujarat Petronet's net profit plunges 53.6% YoY to Rs 220.3 crore in Q4
Trendlyne Marketwatch |
23 May 2025, 10:43AM
From grid to gains: Transformer makers electrify the market
The Baseline |
21 May 2025
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022